PF icon
Feature Partner

Entheon Biomedical

Quick Overview of Entheon Biomedical

Company Status
Public
Private
Non-Profit
Parent Company
CSE Ticker
ENBI
FSE TICKER
OTC Ticker
TSX TICKER
TSX Venture TICKER
NEO TICKER
NASDAQ TICKER
NYSE TICKER

Company Summary

About

Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (“DMT Products”) for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.